Total records found: 466
Hide HeadlineShow Headline
Sort
Release Time Stock Code Stock Short Name Document
Release Time: 06/09/2026 18:37 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2026 (71KB)
Release Time: 01/09/2026 22:48 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Share Scheme]
GRANT OF SHARE OPTIONS AND RESTRICTED SHARES (159KB)
Release Time: 01/09/2026 20:16 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (127KB)
Release Time: 27/08/2026 22:50 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (85KB)
Release Time: 25/08/2026 18:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]
RE-DESIGNATION OF DIRECTOR AND CHANGE OF AUTHORIZED REPRESENTATIVE (144KB)
Release Time: 25/08/2026 18:00 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Interim Results]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026 (455KB)
Release Time: 10/08/2026 17:02 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (131KB)
Release Time: 06/08/2026 17:36 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026 (71KB)
Release Time: 05/08/2026 08:00 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - PRODUCT REVENUE IN THE FIRST HALF AND THE SECOND QUARTER OF 2026 (143KB)
Release Time: 07/07/2026 22:44 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (85KB)
Release Time: 07/07/2026 22:41 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (84KB)
Release Time: 07/07/2026 22:36 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026 (71KB)
Release Time: 25/06/2026 06:16 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (128KB)
Release Time: 25/06/2026 06:10 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Results of AGM / Change in Directors or of Important Executive Functions or Responsibilities]
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 24, 2026 (145KB)
Release Time: 15/06/2026 22:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Share Scheme]
GRANT OF SHARE OPTIONS AND RESTRICTED SHARES (156KB)
Release Time: 04/06/2026 22:28 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026 (71KB)
Release Time: 04/06/2026 16:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF IBI343 (ARCOTATUG TAVATECAN) ACCEPTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA FOR ADVANCED REFRACTORY GASTRIC CANCER (152KB)
Release Time: 29/05/2026 16:49 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Proxy Forms
Form of Proxy for use at the Annual General Meeting to be held on Wednesday, June 24, 2026 (82KB)
Release Time: 29/05/2026 16:45 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]
NOTICE OF ANNUAL GENERAL MEETING (90KB)
Release Time: 29/05/2026 16:40 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory...
More
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory Statement for Repurchase of Shares]
]
(1) PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE NEW SHARES, (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS, (3) PROPOSED RE-APPOINTMENT OF THE EXTERNAL AUDITOR, AND (4) NOTICE OF ANNUAL GENERAL MEETING (235KB)
Release Time: 29/05/2026 06:45 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - ENTERING INTO GLOBAL STRATEGIC COLLABORATION WITH PFIZER TO ACCELERATE DEVELOPMENT OF INNOVATIVE ONCOLOGY MEDICINES (148KB)
Release Time: 22/05/2026 22:41 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Discloseable Transaction / Share Scheme]
DISCLOSEABLE TRANSACTIONS - ACQUISITIONS AND SUBSCRIPTION OF INVESTMENT NOTES AND CLARIFICATION IN RELATION TO GRANT OF SHARE OPTIONS AND RESTRICTED SHARES (170KB)
Release Time: 21/05/2026 16:54 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - NMPA APPROVAL FOR TYVYT (SINTILIMAB INJECTION) IN COMBINATION WITH ELUNATE (FRUQUINTINIB) FOR THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA (73KB)
Release Time: 07/05/2026 16:56 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 (71KB)
Release Time: 30/04/2026 07:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - UPDATE ON THE COMPANY'S PRODUCT REVENUE IN THE FIRST QUARTER OF 2026 (161KB)
Release Time: 28/04/2026 22:56 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report]
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT (11MB)
Release Time: 28/04/2026 22:55 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Financial Statements/ESG Information - [Annual Report]
2025 ANNUAL REPORT (3MB)
Release Time: 09/04/2026 17:54 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 (71KB)
Release Time: 31/03/2026 07:00 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Share Scheme]
GRANT OF SHARE OPTIONS AND RESTRICTED SHARES (168KB)
Release Time: 26/03/2026 17:32 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 (439KB)
Release Time: 25/03/2026 07:00 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
EFFECTIVENESS OF THE STRATEGIC COLLABORATION WITH LILLY AND CLARIFICATION (508KB)
Release Time: 12/03/2026 16:32 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (504KB)
Release Time: 05/03/2026 20:31 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 (70KB)
Release Time: 27/02/2026 19:32 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - JAYPIRCA (PIRTOBRUTINIB) APPROVED IN CHINA FOR THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA (154KB)
Release Time: 08/02/2026 18:06 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - ENTERING INTO STRATEGIC COLLABORATION WITH LILLY TO DEVELOP NEW MEDICINES GLOBALLY IN ONCOLOGY AND IMMUNOLOGY (143KB)
Release Time: 05/02/2026 18:04 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 (71KB)
Release Time: 04/02/2026 18:20 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - ROBUST GROWTH ACHIEVED IN PRODUCT REVENUE IN THE YEAR AND THE FOURTH QUARTER OF 2025 (145KB)
Release Time: 07/01/2026 22:02 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 (69KB)
Release Time: 29/12/2025 07:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - TABOSUN (IPILIMUMAB N01 INJECTION) RECEIVED APPROVAL BY CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION, IN COMBINATION WITH SINTILIMAB AS NEOADJUVANT TREATMENT FOR COLON CANCER (157KB)
Release Time: 07/12/2025 18:05 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - INCLUSION OF SEVEN INNOVATIVE DRUGS INCLUDING TYVYT NEW INDICATION AND SYCUME IN CHINA'S NATIONAL REIMBURSEMENT DRUG LIST (524KB)
Release Time: 05/12/2025 20:31 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Share Scheme]
GRANT OF SHARE OPTIONS AND RESTRICTED SHARES (156KB)
Release Time: 05/12/2025 07:01 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (85KB)
Release Time: 05/12/2025 07:00 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update / Consideration Issue / Issue of Shares under a General Mandate]
CLOSING OF GLOBAL STRATEGIC PARTNERSHIP WITH TAKEDA AND ISSUANCE OF SHARES UNDER GENERAL MANDATE (135KB)
Release Time: 03/12/2025 20:43 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 (68KB)
Release Time: 28/11/2025 16:44 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PECONDLE (PICANKIBART INJECTION) RECEIVED APPROVAL FROM CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS (178KB)
Release Time: 25/11/2025 16:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - MAZDUTIDE 9MG SUPPLEMENTARY APPLICATION ACCEPTED FOR REVIEW BY CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION (181KB)
Release Time: 06/11/2025 16:51 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 (68KB)
Release Time: 30/10/2025 17:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - UPDATE ON THE COMPANY'S PRODUCT REVENUE IN THE THIRD QUARTER OF 2025 (142KB)
Release Time: 22/10/2025 07:44 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update / Consideration Issue / Issue of Shares under a General Mandate]
GLOBAL STRATEGIC COLLABORATION WITH TAKEDA AND ISSUE OF SHARES UNDER GENERAL MANDATE (217KB)
Release Time: 08/10/2025 17:33 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 (68KB)
Release Time: 29/09/2025 16:34 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
2025 INTERIM REPORT (2MB)
Release Time: 19/09/2025 17:20 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - MAZDUTIDE RECEIVED APPROVAL FROM CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES (196KB)
Release Time: 04/09/2025 18:43 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 (68KB)
Release Time: 29/08/2025 22:18 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Share Scheme]
GRANT OF SHARE OPTIONS AND RESTRICTED SHARES (159KB)
Release Time: 27/08/2025 17:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Interim Results]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 (465KB)
Release Time: 26/08/2025 20:20 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (127KB)
Release Time: 26/08/2025 20:11 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE STRATEGY COMMITTEE (132KB)
Release Time: 07/08/2025 17:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - UPDATE ON THE COMPANY'S PRODUCT REVENUE IN THE SECOND QUARTER OF 2025 (143KB)
Release Time: 06/08/2025 16:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 (69KB)
Release Time: 04/08/2025 16:35 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (131KB)
Release Time: 04/07/2025 21:45 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (86KB)
Release Time: 04/07/2025 18:17 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE (139KB)
Release Time: 04/07/2025 16:35 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 (68KB)
Release Time: 30/06/2025 20:26 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Share Scheme]
GRANT OF SHARE OPTIONS AND RESTRICTED SHARES (154KB)
Release Time: 27/06/2025 16:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - FIRST DUAL GCG/GLP-1 RECEPTOR AGONIST MAZDUTIDE RECEIVED APPROVAL BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR CHRONIC WEIGHT MANAGEMENT (204KB)
Release Time: 26/06/2025 07:00 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
PLACING OF NEW SHARES UNDER GENERAL MANDATE (234KB)
Release Time: 25/06/2025 16:31 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Results of AGM]
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 25, 2025 (144KB)
Release Time: 05/06/2025 17:26 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 (68KB)
Release Time: 05/06/2025 07:45 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTED THE NEW DRUG APPLICATION FOR SINTILIMAB COMBINATION WITH FRUQUINTINIB FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA (155KB)
Release Time: 02/06/2025 16:40 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Proxy Forms
Form of Proxy for use at the Annual General Meeting to be held on Wednesday, June 25, 2025 (88KB)
Release Time: 02/06/2025 16:36 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period / Re-election or...
More
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period / Re-election or Appointment of Director subject to Shareholders' Approval / Share Scheme]
]
NOTICE OF ANNUAL GENERAL MEETING (91KB)
Release Time: 02/06/2025 16:31 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director...
More
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval / Share Scheme]
]
(1) PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE NEW SHARES, (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (3) PROPOSED RE-APPOINTMENT OF THE EXTERNAL AUDITOR, (4) GRANT OF RESTRICTED SHARES, AND (5) NOTICE OF ANNUAL GENERAL MEETING (260KB)
Release Time: 08/05/2025 19:09 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 (68KB)
Release Time: 01/05/2025 18:01 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - UPDATE ON THE COMPANY'S PRODUCT REVENUE IN THE FIRST QUARTER OF 2025 (142KB)
Release Time: 29/04/2025 06:08 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report]
2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT (20MB)
Release Time: 29/04/2025 06:01 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Financial Statements/ESG Information - [Annual Report]
2024 ANNUAL REPORT (3MB)
Release Time: 25/04/2025 20:03 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - THE THIRD-GENERATION EGFR TKI LIMERTINIB RECEIVED APPROVAL FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR THE FIRST-LINE TREATMENT OF LUNG CANCER (145KB)
Release Time: 07/04/2025 22:16 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 (68KB)
Release Time: 31/03/2025 22:25 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Terms of Reference of the Nomination Committee]
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE (144KB)
Release Time: 31/03/2025 22:17 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (127KB)
Release Time: 31/03/2025 22:12 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]
CHANGE IN COMPOSITION OF NOMINATION COMMITTEE AND DESIGNATION OF THE LEAD INDEPENDENT NON-EXECUTIVE DIRECTOR (132KB)
Release Time: 28/03/2025 22:42 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Share Scheme]
GRANT OF SHARE OPTIONS AND RESTRICTED SHARES (167KB)
Release Time: 26/03/2025 18:00 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024 (471KB)
Release Time: 14/03/2025 16:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - CHINA'S FIRST IGF-1R MONOCLONAL ANTIBODY SYCUME RECEIVED APPROVAL BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR THE TREATMENT OF THYROID EYE DISEASE (200KB)
Release Time: 11/03/2025 20:24 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (132KB)
Release Time: 06/03/2025 21:54 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 (68KB)
Release Time: 24/02/2025 07:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTS THE NEW DRUG APPLICATION AND GRANTS PRIORITY REVIEW DESIGNATION TO IPILIMUMAB INJECTION IN COMBINATION WITH SINTILIMAB AS NEOADJUVANT TREATMENT FOR COLON CANCER (153KB)
Release Time: 06/02/2025 17:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - UPDATE ON THE COMPANY'S PRODUCT REVENUE IN THE YEAR AND THE FOURTH QUARTER OF 2024 (144KB)
Release Time: 06/02/2025 16:47 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 (68KB)
Release Time: 17/01/2025 07:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - THE THIRD-GENERATION EGFR TKI LIMERTINIB RECEIVED APPROVAL BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR THE TREATMENT OF LUNG CANCER (142KB)
Release Time: 16/01/2025 22:20 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - UNUSUAL PRICE AND TRADING VOLUME MOVEMENT (139KB)
Release Time: 07/01/2025 20:52 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 (68KB)
Release Time: 03/01/2025 07:30 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVES SECOND NEW DRUG APPLICATION OF ROS1 INHIBITOR DOVBLERON (TALETRECTINIB ADIPATE CAPSULE) (521KB)
Release Time: 02/01/2025 07:20 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - ENTERING INTO EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH ROCHE FOR NOVEL DLL3 ADC (144KB)
Release Time: 27/12/2024 18:59 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (126KB)
Release Time: 27/12/2024 18:55 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit...
More
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member / Change of Remuneration Committee Member]
]
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF BOARD COMMITTEES (134KB)
Release Time: 20/12/2024 19:11 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVES ROS1 INHIBITOR DOVBLERON (TALETRECTINIB ADIPATE CAPSULE) (144KB)
Release Time: 05/12/2024 22:43 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Share Scheme]
GRANT OF SHARE OPTIONS AND RESTRICTED SHARES (156KB)
Release Time: 05/12/2024 21:09 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 (68KB)
Release Time: 03/12/2024 18:00 Stock Code: 01801 Stock Short Name: INNOVENT BIO Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED CONDITIONAL APPROVAL FOR TYVYT (SINTILIMAB INJECTION) IN COMBINATION WITH ELUNATE (FRUQUINTINIB) FOR THE TREATMENT OF ADVANCED ENDOMETRIAL CANCER (171KB)
Showing 100 of 466 records
Showing 100 of 466 records
Disclaimer

Information contained in the materials available under the web page containing the hyperlink to this disclaimer is posted on this website for the purpose of providing information to the public in Hong Kong. It is not intended as investment advice and must not be relied on as such. It is the sole responsibility of any person who is located outside of Hong Kong to check and comply with all applicable laws and regulations before accessing and using the materials and information.

Please note that the web page contains materials and information provided to HKEX electronically (including information provided in electronic format) by listed issuers, new listing applicants and relevant parties and there is no agency, employee or partner relationship between HKEX and such parties. HKEX does not assume responsibility for screening, editing or monitoring such materials and the information contained in the materials. The information contained in the materials is not verified by HKEX.

HKEX and/or its subsidiaries take no responsibility for the materials and information available under the web page, make no representation as to their accuracy, reliability, completeness or ownership and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information. Some materials may contain hyperlinks to external websites or web pages for which HKEX and/or its subsidiaries are not responsible. (Please see HKEX's "Hyperlink Policy").

Nothing herein shall constitute or be considered to be a limitation upon or a waiver of the privileges and immunities of HKEX and its subsidiaries, which are specifically reserved.

Copyright exists in the information and materials available under the web page and may belong to HKEX, to the author or to any other party depending on the circumstances of publications. Reproduction, distribution, use and/or linking without consent from the relevant parties is not permitted.

If you believe or are aware that any information contained in the materials is inaccurate, erroneous, unlawful, obscene, defamatory or infringes any intellectual property rights of a third party, please contact HKEX e-Submission by email at: ESSHotline@hkex.com.hk.